Klivira
Request demo

Streamlining Tremfya Prior Authorization for Cardiology Practices

Managing Tremfya prior authorization for cardiology patients requires navigating intricate payer policies and documentation, often diverting critical staff resources from patient care.

Cardiology practices face a dual challenge: high-volume prior authorizations for advanced imaging and interventional procedures, coupled with the complexities of specialty drug approvals. For treatments like Tremfya, efficient PA processing is crucial to ensure timely patient access and optimize revenue cycle performance.

The Unique PA Landscape for Specialty Drugs in Cardiology

While Tremfya may be prescribed for various indications, when a cardiology practice initiates this therapy, it introduces a layer of specialty drug prior authorization complexity. These high-value medications often require extensive documentation, strict adherence to step-therapy protocols, and specific diagnostic criteria that must be meticulously presented to payers or their delegated benefit managers.

Beyond Specialty Drugs: High-Volume Cardiology PA Categories

  • Advanced cardiac imaging (e.g., cardiac MRI, nuclear stress imaging, CCTA)
  • Cardiac catheterization and percutaneous coronary intervention (PCI)
  • Electrophysiology procedures (e.g., ICDs, CRT, ablations)
  • Specialty cardiovascular drugs (e.g., PCSK9 inhibitors, sacubitril/valsartan, SGLT2 inhibitors for HF)

Navigating Payer and Specialty Benefit Management Workflows

Cardiology prior authorizations are frequently routed through specialty benefit-management vendors like Carelon MBM, eviCore (or successor entities), or NIA/Magellan, particularly for advanced cardiac imaging. These vendors apply their own appropriateness criteria, often based on guidelines like the ACR Appropriateness Criteria, creating a fragmented and time-consuming workflow distinct from direct payer portals. Klivira identifies and routes requests automatically.

Critical Documentation for Expedited Cardiology PA

  • Clinical rationale and diagnostic findings supporting the prescribed therapy or procedure.
  • Adherence to ACC/AHA guidelines or ACR Appropriateness Criteria for imaging.
  • Prior treatment history, including trials of preferred agents or maximum tolerated therapies.
  • Specific clinical metrics such as ejection fraction, NYHA functional class, or LDL levels where applicable.
  • Evidence of optimal medical therapy duration for device implant eligibility.

Klivira's Approach to Cardiology and Specialty Drug PA Automation

Klivira's platform is engineered to streamline prior authorization for both complex cardiology services and high-volume specialty drugs like Tremfya. We automate the identification and routing of requests to the correct payer or specialty benefit-management vendor, leveraging policy logic that incorporates guidelines like the ACR Appropriateness Criteria for imaging and payer-specific step-therapy requirements for medications.

Mitigating Common Denial Reasons in Cardiology

Denials for cardiology PAs often stem from inappropriate use criteria for imaging, step-therapy requirements for drugs, or documentation gaps regarding clinical metrics like ejection fraction. Klivira helps mitigate these issues by ensuring complete submission of required clinical data, flagging potential guideline non-adherence, and supporting the longer lead times associated with device PAs.

Frequently asked questions

How does Klivira handle specialty benefit management vendors for cardiology prior authorizations?

Klivira automatically identifies whether a cardiology prior authorization request, such as for advanced imaging or certain specialty drugs, needs to be routed to a specific benefit management vendor like Carelon MBM, eviCore, or NIA/Magellan. Our platform then facilitates the submission through the appropriate channels, streamlining a historically fragmented process.

Can Klivira integrate with our existing EMR system for cardiology PA workflows?

Yes, Klivira is designed for seamless integration with major EMR systems using standards like SMART on FHIR. This integration allows for automated extraction of necessary clinical data, reducing manual data entry and ensuring that relevant patient information is readily available for prior authorization submissions.

Does Klivira support time-sensitive prior authorization requests for urgent cardiology cases?

Klivira's platform can be configured to support expedited pathways for urgent cardiology presentations, such as those involving suspected acute coronary syndrome or syncope workups, where applicable. While payer processes dictate the ultimate speed, our automation helps accelerate the submission and tracking of these critical requests.

How does Klivira assist with the extensive documentation required for specialty drugs like Tremfya in cardiology?

For specialty drugs, Klivira helps ensure all required documentation, such as diagnostic criteria, prior treatment history, and adherence to step-therapy protocols, is compiled and submitted. Our system can flag missing information and guide staff through payer-specific requirements to improve approval rates.

What types of cardiology procedures and services does Klivira support for prior authorization?

Klivira supports a broad range of cardiology services requiring prior authorization, including advanced cardiac imaging (e.g., MRI, CT, nuclear stress), interventional procedures (e.g., cardiac cath, PCI, structural-heart), electrophysiology procedures (e.g., ICDs, ablations), and specialty cardiovascular drugs.

Related coverage

Other tremfya prior authorization by payer

Other tremfya prior authorization by specialty

Ready to automate prior auth for this drug?

See how Klivira automates prior authorizations for your team.

Request a demo